Using prebiotics and probiotics to manage obesity in children with Prader-Willi syndrome
Official title: The Safety and Effectiveness Study of Prebiotics and Probiotics in the Intervention of Obesity in Children With Prader-Willi Syndrome
Run by Children's Hospital of Fudan University · NCT05791604 · Data updated 2026-11-12
This study is testing whether giving probiotics and prebiotics can help children with Prader-Willi syndrome manage their weight and appetite better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 10 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Children's Hospital of Fudan University Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | April 1, 2023 |
| Main results expected | March 31, 2028 |
| Study ends | July 31, 2029 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT05791604 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pre-adolescent children diagnosed with Prader-Willi syndrome and meeting obesity criteria.
✕Probably not a fit
Patients who have recently used weight loss drugs or antibiotics, or those with gastrointestinal diseases affecting digestion, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness and safety of probiotics and prebiotics in controlling appetite and weight gain in children diagnosed with Prader-Willi syndrome (PWS). Participants will be divided into three groups, receiving either probiotics, a combination of probiotics and prebiotics, or a placebo. The study aims to observe changes in body weight, gut microbiota structure, and metabolic levels over the course of the intervention. Given the lack of effective treatments for obesity in PWS, this approach leverages emerging evidence linking gut microbiota to obesity management.
Why it matters
Potential benefit: If successful, this intervention could provide a novel method for managing obesity and appetite in children with Prader-Willi syndrome.
How similar studies have gone: While studies on probiotics and prebiotics for obesity management are emerging, this specific approach in PWS is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pre-adolescent children with Prader Willi syndrome which were definitely diagnosed by gene testing. * Consistent with the diagnostic criteria for obesity. * Not participate in other research projects at present or three months before the research; * Agree to participate in the test and obtain the consent of their parents; voluntarily be the subjects and sign the informed consent form. Exclusion Criteria: * Losing weight in ways other than the intervention measures of this project, such as taking weight loss drugs or known drugs that cause weight change; * Use antibiotics within 1 month before the study and lasted for 3 days or more; * Use probiotics within 1 month before the study and lasted for 3 days or more; * Complicated with liver and renal insufficiency (alanine aminotransferase and serum creatinine indexes exceed 2 times the upper limit of the normal value set by the hospital); * Have gastrointestinal diseases affecting food digestion and absorption (such as severe diarrhea, constipation, severe gastrointestinal inflammation, active gastrointestinal ulcer, acute cholecystitis, etc.); severe diarrhea refers to watery stool 3 or more times a day and lasts for 3 or more days. severe constipation refers to defecation 2 or less times a week with difficulty in defecation; * Surgery was performed within 1 year before the study (except for appendicitis and hernia surgery); * Have hepatitis B, active tuberculosis, AIDS and other infectious diseases; * Those who are suffering from mental illness and are taking psychotropic drugs such as antidepressants.
Where it's running
-
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Wei Lu, Dr
- Email: wei_lu@fudan.edu.cn
- Phone: 86-021-64933281
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Group therapy to help teens with Prader-Willi regulate emotions
Teens with Prader-Willi Syndrome and their families will try a group therapy program to help calm emotions and reduce irritability and anxiety.
-
CSTI-500 in Prader-Willi Syndrome: a dose-escalation study for safety and efficacy
This study tests CSTI-500 in people aged 13–50 with Prader-Willi syndrome to see if it is safe and helps with symptoms, using increasing doses guided by blood levels.
-
Using Tirzepatide to treat obesity in young adults with Prader-Willi Syndrome and hypothalamic obesity
This study is testing if a weight loss medication called Tirzepatide can help young adults with Prader-Willi Syndrome and hypothalamic obesity lose weight and improve their health.
-
Examining autistic traits and sensory profiles in children with Prader-Willi Syndrome
This study looks at how autistic traits and sensory experiences show up in children with Prader-Willi Syndrome to better understand their needs and see if early oxytocin treatment makes a difference.
-
Inclusive physical activity program for adults with intellectual disabilities
This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.
-
Using vagus nerve stimulation to improve emotion and thinking in Prader-Willi Syndrome
This study is testing whether a new treatment using vagus nerve stimulation can help improve emotions and thinking skills in adults with Prader-Willi Syndrome.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.